TISSUEGEN TO SHOWCASE ELUTE® FIBER FOR NERVE REGENERATION AT NEUROSCIENCE 2017

17 Oct TISSUEGEN TO SHOWCASE ELUTE® FIBER FOR NERVE REGENERATION AT NEUROSCIENCE 2017

WHO: TissueGen® Inc., developer of ELUTE® fiber, enables controlled sustained delivery of sensitive pharmaceuticals and biologics from biodegradable fibers for advanced drug delivery, nerve regeneration, and tissue engineering. TissueGen works with leading pharmaceutical, therapeutic, and medical device companies to develop fiber and textile medical devices for use in drug delivery applications such as small diameter vascular grafts and stents, tissue and nerve regeneration, orthopedic devices and sutures.

WHAT: TissueGen will exhibit patented ELUTE fiber in booth 904 at the Society for Neuroscience’s 47th annual meeting, Neuroscience 2017. ELUTE fiber has the potential to revolutionize regenerative medicine applications—including central and peripheral nerve regeneration—through controlled sustained delivery of sensitive biologics and pharmaceuticals from biodegradable fiber.

To set up a meeting, please contact Christopher Knowles at cknowles@tissuegen.com or 1.214.351.1922.

WHERE:

Neuroscience 2017

Booth 904
Walter E. Washington Convention Center
801 Mt Vernon Place NW
Washington, DC 20001

WHEN: Neuroscience 2017 will take place November 11-15, 2017.

To schedule a briefing, please contact Jordan Bouclin at Jordan.bouclin@svmpr.com or 1.401.490.9700.

About TissueGen

TissueGen® Inc. is the developer of ELUTE® fiber, a groundbreaking biodegradable fiber format for advanced drug delivery, nerve regeneration, and tissue engineering. TissueGen has more than four decades of cumulative experience in extruding biodegradable polymer fibers with broad drug delivery capabilities. ELUTE fiber can directly replace standard fibers used in biodegradable textiles currently on the market and provide significantly improved clinical outcomes by delivering therapeutic agents directly at the site of the implant.  By delivering drugs and growth factors at the site of implantation, ELUTE fiber enables medical devices to guide the body’s healing and regenerative processes. For more information, please visit www.tissuegen.com.

# # #

For more information contact:

Jordan Bouclin
SVM Public Relations
1.401.490.9700
jordan.bouclin@svmpr.com

No Comments

Sorry, the comment form is closed at this time.